"Recurrence" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The return of a sign, symptom, or disease after a remission.
| Descriptor ID |
D012008
|
| MeSH Number(s) |
C23.550.291.937
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Recurrence".
Below are MeSH descriptors whose meaning is more specific than "Recurrence".
This graph shows the total number of publications written about "Recurrence" by people in this website by year, and whether "Recurrence" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 39 | 39 |
| 1995 | 0 | 41 | 41 |
| 1996 | 0 | 26 | 26 |
| 1997 | 0 | 37 | 37 |
| 1998 | 0 | 42 | 42 |
| 1999 | 0 | 44 | 44 |
| 2000 | 0 | 43 | 43 |
| 2001 | 0 | 41 | 41 |
| 2002 | 0 | 44 | 44 |
| 2003 | 0 | 56 | 56 |
| 2004 | 2 | 62 | 64 |
| 2005 | 0 | 53 | 53 |
| 2006 | 0 | 76 | 76 |
| 2007 | 0 | 60 | 60 |
| 2008 | 0 | 73 | 73 |
| 2009 | 1 | 63 | 64 |
| 2010 | 0 | 82 | 82 |
| 2011 | 0 | 106 | 106 |
| 2012 | 0 | 97 | 97 |
| 2013 | 0 | 93 | 93 |
| 2014 | 0 | 84 | 84 |
| 2015 | 0 | 84 | 84 |
| 2016 | 0 | 78 | 78 |
| 2017 | 0 | 89 | 89 |
| 2018 | 0 | 98 | 98 |
| 2019 | 0 | 92 | 92 |
| 2020 | 0 | 83 | 83 |
| 2021 | 0 | 72 | 72 |
| 2022 | 0 | 52 | 52 |
| 2023 | 0 | 63 | 63 |
| 2024 | 9 | 31 | 40 |
To return to the timeline,
click here.
Below are the most recent publications written about "Recurrence" by people in Profiles.
-
Outcomes and genetic dynamics of acute myeloid leukemia at first relapse. Haematologica. 2024 Nov 01; 109(11):3543-3556.
-
Evaluating dynamic and predictive discrimination for recurrent event models: use of a time-dependent C-index. Biostatistics. 2024 Oct 01; 25(4):1140-1155.
-
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease. N Engl J Med. 2024 Sep 19; 391(11):1002-1014.
-
Combination low-intensity chemotherapy plus inotuzumab ozogamicin, blinatumomab and rituximab for pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia. Haematologica. 2024 Sep 01; 109(9):3042-3047.
-
Final phase 1 substudy results of ivosidenib for patients with mutant IDH1 relapsed/refractory myelodysplastic syndrome. Blood Adv. 2024 08 13; 8(15):4209-4220.
-
Interreader and Intrareader Reproducibility of 18F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter Studies. J Nucl Med. 2024 Aug 01; 65(8):1239-1243.
-
Recurrent Pleural Effusion Associated With Candida Albicans Infection in Transplanted Kidney: A Case Report. Transplant Proc. 2024 Jul-Aug; 56(6):1509-1512.
-
Selective iliofemoral stent placement for complex pediatric cases: a decade of institutional experience. Pediatr Radiol. 2024 08; 54(9):1540-1548.
-
True-Positive 18F-Flotufolastat Lesions in Patients with Prostate Cancer Recurrence with Baseline-Negative Conventional Imaging: Results from the Prospective, Phase 3, Multicenter SPOTLIGHT Study. J Nucl Med. 2024 Jul 01; 65(7):1080-1086.
-
Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory follicular lymphoma. Haematologica. 2024 07 01; 109(7):2177-2185.